Lagoon edit · Free shipping over $80 · Glass-clear summer drops
Login Register
Description

Pertuzumab y Trastuzumab

Riesgo de leucoencefalopatía multifocal progresiva (LMP)

Dislipidemia mixta

Tratamiento de la enfermedad de Hurler-Scheie o MPS I

AFINITOR® 5 mg es un medicamento oncológico de Novartis formulado con everolimus como principio activo

SELTZ CALCIO+D S ALI 20 TAB EFER NEOMICINA 0.35 G DEXAMETASONA 0.90 MG Pertuzumab y TrastuzumabPRINCIPIO ACTIVO: SUPLEMENTO ALIMENTICIO

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products